Everest Organics Limited (EVERESTO.BO)
INR 257.5
(4.99%)
INR 257.5
(4.99%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 122.26 Million INR | 254.78% |
| 2022 | 122.56 Million INR | -1.41% |
| 2021 | 124.32 Million INR | 14.38% |
| 2020 | 108.69 Million INR | 18.13% |
| 2019 | 92.01 Million INR | -4.82% |
| 2018 | 96.67 Million INR | 36.64% |
| 2017 | 70.75 Million INR | 22.86% |
| 2016 | 57.58 Million INR | -81.69% |
| 2015 | 314.48 Million INR | 8.08% |
| 2014 | 290.96 Million INR | 17.28% |
| 2013 | 248.08 Million INR | 28.07% |
| 2012 | 193.71 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 94.62 Million INR | -19.29% |
| 2023 Q4 | 117.24 Million INR | 8.8% |
| 2023 Q3 | 107.76 Million INR | 80.16% |
| 2023 FY | 434.83 Million INR | 254.78% |
| 2023 Q1 | 102.89 Million INR | 0.47% |
| 2023 Q2 | 59.81 Million INR | -41.87% |
| 2022 FY | 122.56 Million INR | -1.41% |
| 2022 Q1 | 52.67 Million INR | -53.82% |
| 2022 Q2 | 52.05 Million INR | -1.18% |
| 2022 Q3 | 120.91 Million INR | 132.26% |
| 2022 Q4 | 102.41 Million INR | -15.3% |
| 2021 Q3 | 100.13 Million INR | -2.72% |
| 2021 Q1 | 97.33 Million INR | 1.05% |
| 2021 FY | 124.32 Million INR | 14.38% |
| 2021 Q2 | 102.94 Million INR | 5.76% |
| 2021 Q4 | 114.06 Million INR | 13.9% |
| 2020 Q4 | 96.32 Million INR | 2.0% |
| 2020 FY | 108.69 Million INR | 18.13% |
| 2020 Q3 | 94.44 Million INR | -29.71% |
| 2020 Q2 | 134.36 Million INR | 15.14% |
| 2020 Q1 | 116.69 Million INR | 0.52% |
| 2019 FY | 92.01 Million INR | -4.82% |
| 2019 Q2 | 121.58 Million INR | -5.45% |
| 2019 Q1 | 128.58 Million INR | 6.49% |
| 2019 Q3 | 133.47 Million INR | 9.78% |
| 2019 Q4 | 116.09 Million INR | -13.03% |
| 2018 Q3 | 118.73 Million INR | 9.14% |
| 2018 Q2 | 108.78 Million INR | 18.47% |
| 2018 Q1 | 91.82 Million INR | 10.26% |
| 2018 Q4 | 120.75 Million INR | 1.7% |
| 2018 FY | 96.67 Million INR | 36.64% |
| 2017 Q1 | 85.95 Million INR | 32.11% |
| 2017 Q4 | 83.28 Million INR | -13.4% |
| 2017 FY | 70.75 Million INR | 22.86% |
| 2017 Q3 | 96.16 Million INR | 1.34% |
| 2017 Q2 | 94.89 Million INR | 10.4% |
| 2016 Q4 | 65.06 Million INR | -23.72% |
| 2016 FY | 57.58 Million INR | -81.69% |
| 2016 Q1 | 83.59 Million INR | 7.43% |
| 2016 Q2 | 91.58 Million INR | 9.55% |
| 2016 Q3 | 85.3 Million INR | -6.86% |
| 2015 Q1 | 79.03 Million INR | -44.48% |
| 2015 Q3 | 77.54 Million INR | 6.09% |
| 2015 Q2 | 73.09 Million INR | -7.52% |
| 2015 Q4 | 77.81 Million INR | 0.34% |
| 2015 FY | 314.48 Million INR | 8.08% |
| 2014 Q4 | 142.35 Million INR | 170.39% |
| 2014 Q3 | 52.64 Million INR | 3.92% |
| 2014 FY | 290.96 Million INR | 17.28% |
| 2014 Q2 | 50.66 Million INR | 0.0% |
| 2013 Q4 | 131.44 Million INR | 202.86% |
| 2013 Q1 | 33.73 Million INR | -55.64% |
| 2013 Q3 | 43.4 Million INR | 9.86% |
| 2013 FY | 248.08 Million INR | 28.07% |
| 2013 Q2 | 39.5 Million INR | 17.11% |
| 2012 FY | 193.71 Million INR | 0.0% |
| 2012 Q4 | 76.04 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 30.37 Million INR | -302.565% |
| Checkpoint Trends Limited | 5.02 Million INR | -2332.669% |
| GUJARAT INJECT (KERALA) LTD. | 3.85 Million INR | -3073.069% |
| NATURO INDIABULL LIMITED | 3.71 Million INR | -3193.723% |
| NEXUS SURGICAL AND MEDICARE LI | 23.45 Million INR | -421.173% |
| Rajnish Wellness Limited | 14.94 Million INR | -718.196% |
| Rama Vision Limited | 88.37 Million INR | -38.346% |
| Vivo Bio Tech Limited | 57.03 Million INR | -114.361% |